This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
The Market's Earnings Support
by Sheraz Mian
The positive picture emerging from the Q1 earnings season is providing stocks a tangible fundamental support.
Is a Surprise Coming for Live Nation Entertainment (LYV) This Earnings Season?
by Zacks Equity Research
ASurprise might be Coming for Live Nation Entertainment (LYV) stock on the back of its favorable Zacks Rank and positive ESP.
Zacks.com featured highlights: PTC, Covanta Holding, Live Nation Entertainment, Incyte and Vertex Pharmaceuticals
by Zacks Equity Research
Zacks.com featured highlights: PTC, Covanta Holding, Live Nation Entertainment, Incyte and Vertex Pharmaceuticals
5 Toxic Stocks to Shun or Play Short Right Now
by Zacks Equity Research
Just like picking up stocks with strong growth potential, pinpointing toxic stocks and abandoning them at the right time is the key to protect your portfolio from big losses or make profits by short selling them.
AMC Entertainment (AMC) Beats on Q4 Earnings and Revenues
by Zacks Equity Research
AMC Entertainment Holdings Inc. (AMC) reported strong financial results in the fourth quarter of 2016 wherein both the top line and the bottom line outpaced the Zacks Consensus Estimate.
Zacks.com featured highlights: Abercrombie & Fitch, Live Nation Entertainment, Vertex Pharmaceuticals, Etsy and Incyte
by Zacks Equity Research
Zacks.com featured highlights: Abercrombie & Fitch, Live Nation Entertainment, Vertex Pharmaceuticals, Etsy and Incyte
5 Toxic Stocks to Abandon or Play Short Right Now
by Zacks Equity Research
In general, toxic stocks are burdened with huge debt loads and vulnerable to external shocks.
What to Expect from Live Nation (LYV) this Earnings Season?
by Zacks Equity Research
Live Nation Entertainment, Inc. (LYV) is scheduled to report fourth-quarter and full-year 2016 numbers on Feb 23, after the market closes
Zacks.com featured highlights: Live Nation Entertainment, Conns, ConocoPhillips, Etsy and Incyte
by Zacks Equity Research
Zacks.com featured highlights: Live Nation Entertainment, Conns, ConocoPhillips, Etsy and Incyte
5 Toxic Stocks to Dump or Play Short Now
by Zacks Equity Research
Higher price of the toxic stocks can be attributed to either an irrational exuberance associated with them or some serious fundamental lacuna.
Zacks.com featured highlights: Abercrombie & Fitch, Live Nation Entertainment, Herc Holdings, Conns and Vertex Pharmaceuticals
by Zacks Equity Research
Zacks.com featured highlights: Abercrombie & Fitch, Live Nation Entertainment, Herc Holdings, Conns and Vertex Pharmaceuticals
5 Toxic Stocks to Remove from Your Portfolio or Play Short
by Zacks Equity Research
Elevated price levels of toxic stocks can be due to either an irrational exuberance associated with them or some serious fundamental lacunae.
5 Toxic Stocks to Discard or Play Short Right Now
by Zacks Equity Research
Higher price of the toxic stocks can be ascribed to either an irrational exuberance associated with them or some serious fundamental drawbacks.
Forget Buffett, Invest Like A Rock Star!
by Brian Bolan
The summer concert series is a strong one this year, and that could send a few stocks higher.
Stock Picking Ideas from Economic Reports
by Kevin Matras
Kevin Matras goes over how to find winning stock picking ideas in the government's economic reports. Highlighted stocks include ACM, LYV, HCA, ABG and DY.
Chill Out with These 3 Leisure Stocks this Earnings Season
by Zacks Equity Research
The outlook for the leisure industry for 2015 remains positive.
Earnings Acceleration for Future Outperformers
by Kevin Matras
Kevin Matras goes over a screen that can help you find companies with accelerated earnings growth. Highlighted stocks include FSL, LYV, SIGM, TSL and XRTX.